- Home
- PMT vs BBNX Comparison
PMT vs BBNX Comparison
Compare PMT & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMT
- BBNX
- Stock Information
- Founded
- PMT 2009
- BBNX 2015
- Country
- PMT United States
- BBNX United States
- Employees
- PMT N/A
- BBNX N/A
- Industry
- PMT Real Estate Investment Trusts
- BBNX Medical/Dental Instruments
- Sector
- PMT Real Estate
- BBNX Health Care
- Exchange
- PMT Nasdaq
- BBNX Nasdaq
- Market Cap
- PMT 1.1B
- BBNX 967.6M
- IPO Year
- PMT 2009
- BBNX 2025
- Fundamental
- Price
- PMT $12.44
- BBNX $22.23
- Analyst Decision
- PMT Hold
- BBNX Strong Buy
- Analyst Count
- PMT 6
- BBNX 10
- Target Price
- PMT $14.20
- BBNX $26.10
- AVG Volume (30 Days)
- PMT 775.9K
- BBNX 1.1M
- Earning Date
- PMT 10-22-2025
- BBNX 11-06-2025
- Dividend Yield
- PMT 12.89%
- BBNX N/A
- EPS Growth
- PMT N/A
- BBNX N/A
- EPS
- PMT 0.72
- BBNX N/A
- Revenue
- PMT $614,826,000.00
- BBNX $78,022,000.00
- Revenue This Year
- PMT N/A
- BBNX $42.80
- Revenue Next Year
- PMT $27.87
- BBNX $34.58
- P/E Ratio
- PMT $17.25
- BBNX N/A
- Revenue Growth
- PMT 13.07
- BBNX 550.45
- 52 Week Low
- PMT $11.70
- BBNX $8.89
- 52 Week High
- PMT $14.93
- BBNX $26.66
- Technical
- Relative Strength Index (RSI)
- PMT 56.05
- BBNX 56.62
- Support Level
- PMT $12.05
- BBNX $19.07
- Resistance Level
- PMT $12.76
- BBNX $23.08
- Average True Range (ATR)
- PMT 0.18
- BBNX 1.32
- MACD
- PMT 0.05
- BBNX -0.24
- Stochastic Oscillator
- PMT 67.61
- BBNX 70.86
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.